Solesence (SLSN) Liabilities and Shareholders Equity (2010 - 2026)

Solesence (SLSN) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $46.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Liabilities and Shareholders Equity fell 22.55% year-over-year to $46.4 million; the trailing twelve-month figure through Jun 2026 stood at $191.0 million (down 11.18% YoY), and the FY2025 full-year result was $46.5 million, down 6.99% from the prior year.
• Liabilities and Shareholders Equity improved to $46.4 million in Q2 2026 per SLSN's latest filing, from $44.0 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $60.0 million in Q2 2025 and bottomed at $31.5 million in Q1 2023.
• Historically, Liabilities and Shareholders Equity has averaged $41.7 million across 5 years, with a median of $39.7 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity surged 115.07% in 2022, then declined 22.74% in 2026.
• Over 5 years, Liabilities and Shareholders Equity stood at $33.6 million in 2022, then decreased by 2.02% to $32.9 million in 2023, then jumped by 52.07% to $50.0 million in 2024, then declined by 6.99% to $46.5 million in 2025, then dropped by 0.15% to $46.4 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $46.4 million, $44.0 million, and $46.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.